These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32925053)

  • 1. Microbleeds and Medial Temporal Atrophy Determine Cognitive Trajectories in Normal Aging: A Longitudinal PET-MRI Study.
    Montandon ML; Herrmann FR; Garibotto V; Rodriguez C; Haller S; Giannakopoulos P
    J Alzheimers Dis; 2020; 77(4):1431-1442. PubMed ID: 32925053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of Cognitive Trajectories in Normal Aging: A Longitudinal PET-MRI Study in a Community-based Cohort.
    Herrmann FR; Montandon ML; Garibotto V; Rodriguez C; Haller S; Giannakopoulos P
    Curr Alzheimer Res; 2021; 18(6):482-491. PubMed ID: 34602046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers.
    Giannakopoulos P; Montandon ML; Herrmann FR; Hedderich D; Gaser C; Kellner E; Rodriguez C; Haller S
    Eur Radiol; 2022 Nov; 32(11):7833-7842. PubMed ID: 35486172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of mesial temporal lobe volume loss in older individuals with preserved cognition: a longitudinal PET amyloid study.
    Montandon ML; Herrmann FR; Garibotto V; Rodriguez C; Haller S; Giannakopoulos P
    Neurobiol Aging; 2020 Mar; 87():108-114. PubMed ID: 32057528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Subtle Cognitive Decline in Normal Aging: Added Value of Quantitative MRI and PET Imaging.
    Giannakopoulos P; Montandon ML; Rodriguez C; Haller S; Garibotto V; Herrmann FR
    Front Aging Neurosci; 2021; 13():664224. PubMed ID: 34322007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial temporal lobe atrophy ratings in a large 75-year-old population-based cohort: gender-corrected and education-corrected normative data.
    Velickaite V; Ferreira D; Cavallin L; Lind L; Ahlström H; Kilander L; Westman E; Larsson EM
    Eur Radiol; 2018 Apr; 28(4):1739-1747. PubMed ID: 29124383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Microbleeds: Relationship to Antithrombotic Medications.
    Graff-Radford J; Lesnick T; Rabinstein AA; Gunter JL; Przybelski SA; Noseworthy PA; Preboske GM; Mielke MM; Lowe VJ; Knopman DS; Petersen RC; Kremers WK; Jack CR; Vemuri P; Kantarci K
    Stroke; 2021 Jul; 52(7):2347-2355. PubMed ID: 33966498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality Impact on Alzheimer's Disease - Signature and Vascular Imaging Markers: A PET-MRI Study.
    Giannakopoulos P; Rodriguez C; Montandon ML; Garibotto V; Haller S; Herrmann FR
    J Alzheimers Dis; 2022; 85(4):1807-1817. PubMed ID: 34958019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study.
    van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Pantoni L; Basile AM; Inzitari D; Erkinjuntti T; Wahlund LO; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1497-500. PubMed ID: 16227537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of longitudinal amyloid and vascular changes on lobar microbleeds.
    Kim YJ; Kim HJ; Park JH; Kim S; Woo SY; Kwak KC; Lee JM; Jung NY; Kim JS; Choe YS; Lee KH; Moon SH; Lee JH; Kim YJ; Werring DJ; Na DL; Seo SW
    Neurology; 2016 Oct; 87(15):1575-1582. PubMed ID: 27629091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medial temporal lobe atrophy and posterior atrophy scales normative values.
    Cotta Ramusino M; Altomare D; Bacchin R; Ingala S; Bnà C; Bonetti M; Costa A; Barkhof F; Nicolosi V; Festari C; Frisoni GB; Boccardi M
    Neuroimage Clin; 2019; 24():101936. PubMed ID: 31382240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease.
    García-Alberca JM; Florido M; Cáceres M; Sánchez-Toro A; Lara JP; García-Casares N
    Psychogeriatrics; 2019 Jan; 19(1):46-54. PubMed ID: 30084177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals.
    Gregg NM; Kim AE; Gurol ME; Lopez OL; Aizenstein HJ; Price JC; Mathis CA; James JA; Snitz BE; Cohen AD; Kamboh MI; Minhas D; Weissfeld LA; Tamburo EL; Klunk WE
    JAMA Neurol; 2015 Sep; 72(9):1021-8. PubMed ID: 26167811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
    Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM
    Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.
    Korf ES; Wahlund LO; Visser PJ; Scheltens P
    Neurology; 2004 Jul; 63(1):94-100. PubMed ID: 15249617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatically computed rating scales from MRI for patients with cognitive disorders.
    Koikkalainen JR; Rhodius-Meester HFM; Frederiksen KS; Bruun M; Hasselbalch SG; Baroni M; Mecocci P; Vanninen R; Remes A; Soininen H; van Gils M; van der Flier WM; Scheltens P; Barkhof F; Erkinjuntti T; Lötjönen JMP;
    Eur Radiol; 2019 Sep; 29(9):4937-4947. PubMed ID: 30796570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
    Oosterman JM; Vogels RL; van Harten B; Gouw AA; Scheltens P; Poggesi A; Weinstein HC; Scherder EJ
    Brain Cogn; 2008 Nov; 68(2):128-33. PubMed ID: 18450353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects.
    Haller S; Montandon ML; Rodriguez C; Garibotto V; Herrmann FR; Giannakopoulos P
    Neurodegener Dis; 2019; 19(3-4):139-147. PubMed ID: 31846965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.